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ealth  conditions  for  travellers  to  Saudi  Arabia  for
he  Umra  and  Hajj  pilgrimage  to  Mecca:
equirements  for  2012  (1433)
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phe  Ministry  of  Health  of  Saudi  Arabia  has  issued
he following  requirements  and  recommendations
or entry  visas  for  the  Hajj  and  Umra  seasons  in
012.
ellow fever
)  In  accordance  with  the  International  Health
egulations 2005  [1]  all  travellers  arriving  from
ountries  or  areas  at  risk  of  yellow  fever  (listed
elow) must  present  a  valid  yellow  fever  vacci-
ation certiﬁcate  showing  that  the  person  was
accinated  at  least  10  days  previously  and  not  more
han 10  years  before  arrival  at  the  border.
In the  absence  of  such  a  certiﬁcate,  the  individ-
al will  be  placed  under  strict  surveillance  for  6
ays from  the  date  of  vaccination  or  the  last  date
f potential  exposure  to  infection,  whichever  is
arlier. Health  ofﬁces  at  entry  points  will  be  respon-
ible for  notifying  the  appropriate  Director  General
f Health  Affairs  in  the  region  or  governorate  about
he temporary  place  of  residence  of  the  visitor.
The following  countries/areas  are  at  risk  of
ellow fever  transmission  (as  deﬁned  by  the  Inter-
ational  travel  and  health  2012  [2]).
Africa:
Angola,  Benin,  Burkina  Faso,  Burundi,  Cameroon,
entral African  Republic,  Chad,  Congo,  Cote
’Ivoire, Democratic  Republic  of  the  Congo,  Equa-
orial Guinea,  Ethiopia,  Gabon,  Guinea,  Guinea
issau,  Gambia,  Ghana,  Kenya,  Liberia,  Mali,
 This report will appear in the WHO publication WER, issue
o. 30, Volume no. 87, scheduled for release 27 July 2012.
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oi:10.1016/j.jiph.2012.03.001auritania,  Niger,  Nigeria,  Rwanda,  Senegal,  Sierra
eone, Sudan,  South  Soudan,  Togo,  Uganda
South and  Central  America:
Argentina,  Bolivarian  Republic  of  Venezuela,
razil, Colombia,  Ecuador,  French  Guiana,  Guyana,
anama,  Paraguay,  Peru,  Plurinational  State  of
olivia, Suriname,  Trinidad  and  Tobago.
b) Aircrafts,  ships  and  other  means  of  transporta-
ion coming  from  countries  affected  by  yellow  fever
re requested  to  submit  a  certiﬁcate  indicating  that
t applied  disinsection  in  accordance  with  methods
ecommended  by  WHO.
In accordance  with  the  International  Health  Reg-
lations  2005,  all  arriving  ships  will  be  requested  to
rovide to  the  competent  authority  a valid  Ship  San-
tation Certiﬁcate.  Ships  arriving  from  areas  at  risk
or yellow  fever  transmission  may  also  be  required
o submit  to  inspection  to  ensure  they  are  free  of
ellow fever  vectors,  or  disinsected,  as  a  condition
f granting  free  pratique  (including  permission  to
nter a  port,  to  embark  or  disembark  and  to  dis-
harge  or  load  cargo  or  stores).
eningococcal meningitis
)  Visitors  from  all  countries:
Visitors  arriving  for  the  purpose  of  Umra  or
ilgrimage or  for  seasonal  work  are  required  to
roduce  a  certiﬁcate  of  vaccination  with  the
uadrivalent  (ACYW135)  vaccine  against  meningi-
is issued  not  more  than  3 years  previously  and  not
ess than  10  days  before  arrival  in  Saudi  Arabia.  The
esponsible  authorities  in  the  visitor’s  country  of
rigin should  ensure  that  adults  and  children  over
 King  Saud  Bin  Abdulaziz  University  for  Health  Sciences.  All  rights  reserved.
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the  age  of  2  years  are  given  1  dose  of  the  quadriva-
lent polysaccharide  (ACYW135)  vaccine.
b) Visitors  from  African  countries:
For Visitors  arriving  from  countries  in  the
African meningitis  belt,  namely  Benin,  Burkina
Faso, Cameroon,  Chad,  Central  African  Republic,
Côte d’Ivoire,  Eritrea,  Ethiopia,  Gambia,  Guinea,
Guinea-Bissau,  Mali,  Niger,  Nigeria,  Senegal  and
Sudan, in  addition  to  the  above  stated  require-
ments, ciproﬂoxacin  tablets  (500  mg)  chemopro-
phylaxis will  be  administered  at  port  of  entry  to
lower the  rate  of  carriers.
c)  Interior  pilgrims  and  the  Hajj  workers:
Vaccination  with  quadrivalent  (ACYW135)  vac-
cine is  required  for:
- all  citizens  and  residents  of  Medina  and  Mecca
who have  not  been  vaccinated  during  the  past  3
years;
- all  citizens  and  residents  undertaking  the  Hajj;
- all Hajj  workers  who  have  not  been  vaccinated  in
the past  3  years;
- any  individual  working  at  entry  points  or  in  direct
contact  with  pilgrims  in  Saudi  Arabia.
Poliomyelitis
All  travellers  arriving  from  polio-endemic  countries
and  re-established  transmission  countries,  namely,
Afghanistan,  Angola,  Chad,  the  Democratic  Repub-
lic of  Congo,  India,  Nigeria,  Pakistan  regardless  of
age and  vaccination  status,  should  receive  1  dose
of oral  polio  vaccine  (OPV).  Proof  of  OPV  vaccina-
tion at  least  6  weeks  prior  departure  is  required  to
apply for  entry  visa  for  Saudi  Arabia  and  travellers
will also  receive  1  dose  of  OPV  at  borders  points
on arrival  in  Saudi  Arabia.  The  same  requirements
are valid  for  travellers  from  recently  endemic  coun-
tries at  high  risk  of  re-importation  of  poliovirus,  i.e.
India.
All visitors  age  under  15  years  travelling  to
Saudi Arabia  from  countries  reporting  polio  follow-
ing importation  or  due  to  vaccine-derived  poliovirus
in the  past  12  months  (as  of  mid-February,  2012,  see
list below)  should  be  vaccinated  against  poliomyeli-
tis with  the  (OPV).  Proof  of  OPV  vaccination  is
required  6  weeks  prior  the  application  for  entry
visa. Irrespective  of  previous  immunization  history,
all visitors  under  15  years  arriving  in  Saudi  Arabia
will also  receive  1 dose  of  OPV  at  border  points.Polio cases  related  to  wild  poliovirus  importa-
tion or  to  vaccine-derived  poliovirus  have  been
registered  during  the  past  12  months  in  the  follow-
ing countries:  Cameroon,  Central  African  Republic,
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ote  d’Ivoire,  Kenya,  Mali,  Niger,  Somalia  and
emen.
easonal inﬂuenza
he  Ministry  of  Health  of  Saudi  Arabia  recommends
hat international  pilgrims  be  vaccinated  against
easonal  inﬂuenza  before  arrival  into  the  king-
om of  Saudi  Arabia  with  WHO  approved  strains
peciﬁc to  the  northern  or  southern  hemispheres,
articularly those  at  increased  risk  for  severe  com-
lications  (e.g.  the  elderly  over  65  years  of  age,
eople with  pre-existing  medical  conditions  such
s chronic  respiratory  or  heart  diseases,  hepatic
r renal  disorders,  neuromuscular  or metabolic  dis-
ases including  diabetes  or  immunocompromised
onditions  due  to  various  reasons  such  as  HIV
nfection or  immunosuppressive  therapy).  Pregnant
omen  can  also  be  considered  for  vaccination.
In Saudi  Arabia,  seasonal  inﬂuenza  vaccination
s recommended  for  internal  pilgrims,  particularly
hose at  risk  described  above,  and  all  health  staff
orking  in  the  Hajj  premises.
ealth education
ealth  authorities  in  countries  of  origin  are
equired to  provide  information  to  pilgrims  on
nfectious  diseases  symptoms,  methods  of  transmis-
ion, complications,  and  means  of  prevention.
ood
ajj  and  Umrah  performers  are  not  allowed  to  bring
resh food  in  Saudi  Arabia.  Only  properly  canned  or
ealed food  or  food  stored  in  containers  with  easy
ccess for  inspection  is  allowed  in  small  quantities,
ufﬁcient for  one  person  for  the  duration  of  his  or
er trip.
nternational outbreaks responses
pdating  immunization  against  vaccine-
reventable diseases  in  all  travellers  is  strongly
ecommended. With  the  recent  resurgence  of
easles and  rubella  cases,  special  attention
s needed  for  both  of  these  vaccines  to  avoid
idespread outbreaks  with  this  virus  during  this
ear Hajj  and  Umrah.  Preparation  for  interna-
ional travel  provides  opportunity  to  review  the
mmunization  status  of  travellers.  Incompletely
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[ealth  conditions  for  travellers  to  Saudi  Arabia  
mmunized  travellers  can  be  offered  routine
accinations recommended  in  national  immuniza-
ion schedules  (these  usually  include  diphtheria,
etanus, pertussis,  polio,  measles,  and  mumps),
n addition  to  those  needed  for  the  speciﬁc  travel
e.g.  meningococcal  vaccination  for  Hajj).  In  Inter-
ational  Travel  and  Health  2012  WHO  recommends
hat travellers  ensure  immunity  against  measles
y having  at  least  2  doses  of  vaccine  and  against
ubella by  one  dose  of  vaccine.
In the  event  of  a  public  health  emergency  of
nternational health  concern,  or  in  the  case  of  any
isease outbreak  subject  to  notiﬁcation  under  the
nternational  Health  Regulations  2005,  the  health
uthorities  in  Saudi  Arabia  will  undertake  additional
reventive  precautions  (not  included  in  the  mea-
ures mentioned  above)  following  consultation  with
Available  online  at  www115
HO  and  necessary  to  avoid  the  spread  of  infection
uring the  pilgrimage  or  on  return  to  their  country
f origin.
eferences
1] International health regulations 2005. Geneva: WHO; 2005
[available from: http://www.who.int/ihr].
2] International travel and health. Geneva: WHO; 2012 [avail-
able from: http://www.who.int/ith in March 2012].
Ziad  A.  Memish ∗
Abdullah  A.  Al  Rabeeah
Saudi  Ministry  of  Health,  Riyadh,  Saudi  Arabia
∗Corresponding  author.
E-mail  address:  zmemish@yahoo.com
(Z.A.  Memish)
.sciencedirect.com
